PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
02-Sep-2025 Servier and IDEAYA Biosciences Partner to Bring Darovasertib, a Promising Uveal Melanoma Treatment, to Patients Worldwide Servier
02-Sep-2025 Florence Announces AI-Assisted Workflows to Transform Clinical Trials ACCESS Newswire
02-Sep-2025 Coulter Partners secures Dieter Weinand as Board Chair for AstriVax Therapeutics Coulter Partners
02-Sep-2025 Fenja Capital II A/S Requests Conversion of All Outstanding Convertibles for a Total Nominal Amount of SEK 7.5 Million ACCESS Newswire
02-Sep-2025 Alligator Announces Evaluation and Option Agreement Covering RUBY(TM) Antibody Format ACCESS Newswire
02-Sep-2025 Medical Care Technologies Inc. (OTC PINK:MDCE) Unveils Patent-Pending AI Mental Health Tracker Targeting $400 Billion Market ACCESS Newswire
02-Sep-2025 Brenus Pharma Announces First Patients Dosed in its First-in-Human Trial Evaluating STC-1010, a Next-Generation Immunotherapy Businesswire
02-Sep-2025 NAYA Therapeutics to Partner With Atley Solutions to Accelerate Development & Commercialization of Its Astatine-211 Radio Pharmaceuticals ACCESS Newswire
02-Sep-2025 VSee Health Teleradiology Expands to 25 Hospitals for an Estimated $3.0 Million Annualized Revenue ACCESS Newswire
02-Sep-2025 New World Medical Introduces the Ahmed ClearPath(R) ST Glaucoma Drainage Device ACCESS Newswire
02-Sep-2025 IGC Pharma Expands CALMA Phase 2 Trial to Island Health's Royal Jubilee Hospital in Canada ACCESS Newswire
02-Sep-2025 CASI Pharmaceuticals Appoints Barbara Krebs-Pohl, PhD to Board of Directors ACCESS Newswire
02-Sep-2025 MicroGenDX's New Testing Platform Cuts NGS Turnaround Time to 24 Hours for Life-Saving Decisions ACCESS Newswire
02-Sep-2025 Richmond Pharmacology Appoints Patrick Ramiah as Director of Clinical Project Delivery & Operational Excellence Richmond Pharmacology
02-Sep-2025 Life Science Analytics Market Report 2025-2030 with Profiles of Leading Players - IBM Corporation, IQVIA, Wipro, Accenture, Microsoft VMR
02-Sep-2025 1933 Industries Announces Repurchase and Cancellation of Convertible Debentures ACCESS Newswire
02-Sep-2025 QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access to Rapid Syndromic Testing Businesswire
02-Sep-2025 Naobios, Nuvonis and European Vaccine Initiative collaborate on manufacturing influenza challenge agent Naobios, Nuvonis and European Vaccine Initiative
02-Sep-2025 Ablexis Announces Validation and Availability of AlivaMab(R) Mouse-NGX ACCESS Newswire
02-Sep-2025 AlivaMab Biologics Announces Milestone- and Royalty-Free Access to AlivaMab(R) Mouse for Human Antibody Drug Discovery Services ACCESS Newswire